EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Insights Into Heart-Tumor Interactions in Heart Failure

Tal Caller iD, Kathryn J Moore iD, Lorenz H Lehmann iD, Sean M Wu iD, Jonathan Leor iD

Circulation Research · 23.05.2025 · 136 (11) · 1262-1285

DOI: 10.1161/circresaha.124.325490 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 23.05.2025. Verfasst von Tal Caller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neufeld and Tamman Cardiovascular Research Institutes, Faculty of Medical and Health Sciences, Tel Aviv University, Israel (T.C., J.L.). Hauptthemen laut MEDLINE: Heart Failure, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) often coexists with cancer. Beyond the known cardiotoxicity of some cancer treatments, HF itself has been associated with increased cancer incidence. The 2 conditions share common risk factors, mechanisms, and interactions that can worsen patient outcomes. The bidirectional relationship between HF and cancer presents a complex interplay of factors that are not fully understood. Recent preclinical evidence suggests that HF may promote tumor growth via the release of protumorigenic factors from the injured heart, revealing HF as a potentially protumorigenic condition. Our review discusses the biological crosstalk between HF and cancer, emphasizing the impact of HF on tumor growth, with inflammation, and modulating the immune system as central mechanisms. We further explore the clinical implications of this connection and propose future research directions. Understanding the mechanistic overlap and interactions between HF and cancer could lead to new biomarkers and therapies, addressing the growing prevalence of both conditions and enhancing approaches to diagnosis, prevention, and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureNeoplasmsHumansAnimalsRisk Factors

Stichwörter der Autor:innen

biomarkersheart failureimmune systeminflammationneoplasmsrisk factors

Autor:innen und Institutionen

  • Neufeld and Tamman Cardiovascular Research Institutes, Faculty of Medical and Health Sciences, Tel Aviv University, Israel (T.C., J.L.).
  • Lev Leviev Cardiovascular and Thoracic Center, Sheba Medical Center, Tel Hashomer, Israel (T.C., J.L.).
  • Department of Medicine, Cardiovascular Research Center, New York University Grossman School of Medicine (K.J.M.).
  • Department of Cardiology, University Hospital Heidelberg, Germany (L.H.L.).
  • German Center of Cardiovascular Research (DZHK), Partnersite Heidelberg/Mannheim, Germany (L.H.L.).
  • German Cancer Research Center (DKFZ), Heidelberg, Germany (L.H.L.).

ORCID-Profile: Tal Caller, Kathryn J Moore, Lorenz H Lehmann, Sean M Wu, Jonathan Leor

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Caller, T., Moore, K. J., Lehmann, L. H., Wu, S. M., & Leor, J. (2025). Insights Into Heart-Tumor Interactions in Heart Failure. Circulation Research, 136(11), 1262-1285. https://doi.org/10.1161/circresaha.124.325490

Vancouver

Caller T, Moore KJ, Lehmann LH, Wu SM, Leor J. Insights Into Heart-Tumor Interactions in Heart Failure. Circulation Research. 2025;136(11):1262-1285. doi:10.1161/circresaha.124.325490

BibTeX
@article{Caller2025,
  author = {Caller, Tal and Moore, Kathryn J and Lehmann, Lorenz H and Wu, Sean M and Leor, Jonathan},
  title = {Insights Into Heart-Tumor Interactions in Heart Failure},
  journal = {Circulation Research},
  year = {2025},
  volume = {136},
  number = {11},
  pages = {1262--1285},
  doi = {10.1161/circresaha.124.325490}
}
Kostenlos starten →